NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-058-2015-1-CN-03 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER CN National Stage 201280066947.1 Pending
NCI E-494-2013-0-CA-04 Methods of Preparing Anti-human Papillomavirus Antigen T Cells CA National Stage 2918080 Pending
NCI E-121-2013-0-GB-08 METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER GB EP 14745047.2 Issued
NCI E-121-2013-0-FR-07 METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER FR EP 14745047.2 Issued
NCI E-121-2013-0-DE-06 METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER DE EP 14745047.2 Issued
NCI E-121-2013-0-EP-03 METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER EP National Stage 14745047.2 Issued
NCI E-159-2009-1-US-03 LAT Adapter Molecule for Enhanced T-Cell Signaling and Method of Use US CON 14/329,736 9649339 Issued PDF
NCI E-121-2013-0-PCT-02 METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER PCT PCT PCT/US2014/046294 Expired
NEI E-192-2014-0-US-01 Surgical Tool and Method for Ocular Tissue Transplantation US 62/023,289 Abandoned
NIDCR E-186-2009-0-EP-04 Apototic Cell-Mediated Induction Of Antigen-specific Regulatory T Cells for the Therapy of Autoimmune Disease in Animals and Humans EP National Stage 14822269.8 Issued
NIDCR E-186-2009-0-DE-05 Apototic Cell-Mediated Induction Of Antigen-specific Regulatory T Cells for the Therapy of Autoimmune Disease in Animals and Humans DE EP 14822269.8 Issued
NIDCR E-186-2009-0-FR-06 Apototic Cell-Mediated Induction Of Antigen-specific Regulatory T Cells for the Therapy of Autoimmune Disease in Animals and Humans FR EP 14822269.8 Issued
NIDCR E-186-2009-0-GB-07 Apototic Cell-Mediated Induction Of Antigen-specific Regulatory T Cells for the Therapy of Autoimmune Disease in Animals and Humans GB EP 14822269.8 Issued
NICHD E-493-2013-0-PCT-02 Method for Predicting and Detecting Tumor Metastasis In Kidney Cancer PCT PCT PCT/US2014/046124 Expired
NIDCR E-186-2009-0-PCT-02 Apototic Cell-mediated Induction Of Antigen-specific Regulatory T Cells for the Therapy of AutoImmune Disease in Animals and Humans PCT PCT PCT/US14/046065 Expired
NCI E-136-2014-0-US-01 CONSTANT DOMAIN ANTIBODY SCAFFOLDS US 62/022,810 Abandoned
NCI E-482-2013-0-CA-03 PHOTOACTIVATABLE LIPID-BASED NANOPARTICLES AS VEHICLES FOR DUAL AGENT DELIVERY CA National Stage 2917545 Issued
NCI E-482-2013-0-FR-08 Photoactivable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery FR EP 14745037.3 Issued
NCI E-482-2013-0-DE-07 Photoactivable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery DE EP 14745037.3 Issued
NCI E-482-2013-0-CH-06 Photoactivable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery CH EP 14745037.3 Issued
NCI E-482-2013-0-GB-09 Photoactivable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery GB EP 14745037.3 Issued
NCI E-482-2013-0-EP-04 Photoactivable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery EP National Stage 14745037.3 Issued
NCI E-767-2013-0-CA-03 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules CA National Stage 2917919 Issued
NCI E-767-2013-0-BE-12 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules BE EP 14823231.7 Issued
NCI E-767-2013-0-NL-18 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules NL EP 14823231.7 Issued
NCI E-767-2013-0-EP-06 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules EP National Stage 14823231.7 Issued
NCI E-767-2013-0-GR-16 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules GR EP 14823231.7 Issued
NCI E-767-2013-0-IT-17 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules IT EP 14823231.7 Issued
NCI E-767-2013-0-ES-14 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules ES EP 14823231.7 Issued
NCI E-767-2013-0-PL-19 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules PL EP 14823231.7 Issued
NCI E-767-2013-0-SE-20 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules SE EP 14823231.7 Issued
NCI E-767-2013-0-CH-22 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules CH EP 14823231.7 Issued
NCI E-767-2013-0-TR-21 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules TR EP 14823231.7 Issued
NCI E-767-2013-0-FR-15 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules FR EP 14823231.7 Issued
NCI E-767-2013-0-DE-13 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules DE EP 14823231.7 Issued
NCI E-767-2013-0-JP-04 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules JP National Stage 2016-525458 Issued
NCI E-767-2013-0-AU-05 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules AU National Stage 2014287244 Issued
NCI E-482-2013-0-PCT-02 Photo-activable Lipid-based Nanoparticles As Vehicles For Dual Agent Delivery PCT PCT PCT/US2014/045922 Expired
NCI E-767-2013-0-PCT-02 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules PCT PCT PCT/US14/046003 Expired
NCATS E-234-2012-0-CR-09 PAK Inhibitors For the Treatment of Fragile X Syndrome CR National Stage 2014-0251 Pending
NINDS E-101-2012-1-CA-06 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS CA National Stage 2917159 Issued
NINDS E-101-2012-1-PCT-02 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS PCT PCT PCT/US2014/045731 Expired
NINDS E-101-2012-1-US-03 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS US ORD 14/325,988 Abandoned
NINDS E-101-2012-1-EP-10 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS EP National Stage 14822407.4 Abandoned
NCI E-119-2013-0-PCT-02 Method for Synthesizing Selectively Labeled RNA PCT PCT PCT/US14/045784 Expired
NINDS E-101-2012-1-AU-04 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS AU National Stage 2014287418 Abandoned
NINDS E-101-2012-1-IN-12 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS IN National Stage 11913/DELNP/2015 Pending
NINDS E-101-2012-1-IL-11 DIHYDROXYPHENYL NEUROTRANSMITTER COMPOUNDS, COMPOSITIONS AND METHODS IL National Stage 243488 Abandoned
CC E-066-2010-0-JP-08 SYSTEM AND METHOD FOR FUSING REAL-TIME ULTRASOUND IMAGES WITH PRE-ACQUIRED MEDICAL IMAGES JP DIV 2014-140004 Pending
NCI E-001-2012-0-US-06 NATIVE AND AGONIST CTL EPITOPES OF THE MUC1 TUMOR ANTIGEN US National Stage 14/370,595 10138271 Issued PDF